Net Cash Provided by (Used in) Operating Activities |
-15.3K |
USD |
+6.93% |
Q2 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
15K |
USD |
-1.32% |
Q2 2024 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
-3.31K |
USD |
|
Q2 2022 |
Q1 2024 |
Common Stock, Shares Authorized |
90M |
shares |
0% |
Q2 2024 |
Q1 2025 |
Common Stock, Shares, Issued |
16.3M |
shares |
0% |
Q2 2024 |
Q1 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q1 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-300 |
USD |
+75.8% |
Q2 2024 |
Q1 2025 |
Deferred Tax Assets, Valuation Allowance |
346K |
USD |
+15.2% |
Q2 2024 |
Q1 2025 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q2 2024 |
Q1 2025 |
Deferred Tax Assets, Gross |
346K |
USD |
+15.2% |
Q2 2024 |
Q1 2025 |
Payments to Acquire Property, Plant, and Equipment |
3.31K |
USD |
|
Q2 2022 |
Q1 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
346K |
USD |
+15.2% |
Q2 2024 |
Q1 2025 |
Preferred Stock, Shares Issued |
0 |
shares |
|
Q2 2024 |
Q1 2025 |
Preferred Stock, Shares Authorized |
10M |
shares |
0% |
Q2 2024 |
Q1 2025 |
Additional Paid in Capital |
31.5K |
USD |
0% |
Q2 2024 |
Q1 2025 |
Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q2 2024 |
Q1 2025 |
Amortization of Intangible Assets |
0 |
USD |
|
Q2 2024 |
Q1 2025 |
Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2024 |
Q1 2025 |